Skip to main content

Rubius Therapeutics, Inc.

RUBYDelisted Mar 28, 2023
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001709401

Rubius Therapeutics, Inc. was delisted on Mar 28, 2023; its insiders filed their last Form 4 on Feb 27, 2023; 42 institutions reported holding it in 13F filings for Q4 2022, worth $11.2M in total; no superinvestor held it.

13F holders, Q2 2023

Institutional positions in Rubius Therapeutics, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

RUBY is no longer listed, and 13F filings after Q4 2022 list far fewer holders. See Q4 2022

Institutional holders
0
−7 vs. Q1 2023
Shares held
0
−2.96M (−100.0%) vs. Q1 2023
Total value
$0
−$61.3K (−100.0%) vs. Q1 2023
New holders
0
0 more added
Sold out
7
0 more reduced

Compare with Q1 2023: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting RUBY on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2023: 0 institutions
Q1 2021: 105 institutionsQ2 2021: 108 institutionsQ3 2021: 105 institutionsQ4 2021: 108 institutionsQ1 2022: 117 institutionsQ2 2022: 73 institutionsQ3 2022: 62 institutionsQ4 2022: 42 institutionsQ1 2023: 7 institutionsQ2 2023: 0 institutionsQ3 2023: 0 institutionsQ4 2023: 0 institutionsQ1 2024: 0 institutionsQ2 2024: 0 institutionsQ3 2024: 0 institutionsQ4 2024: 0 institutionsQ1 2025: 0 institutionsQ2 2025: 0 institutionsQ3 2025: 0 institutionsQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ2 2023: $0
Q1 2021: $2.23BQ2 2021: $2.09BQ3 2021: $1.55BQ4 2021: $863.6MQ1 2022: $493.9MQ2 2022: $66.6MQ3 2022: $29.7MQ4 2022: $11.2MQ1 2023: $61.3KQ2 2023: $0Q3 2023: $0Q4 2023: $0Q1 2024: $0Q2 2024: $0Q3 2024: $0Q4 2024: $0Q1 2025: $0Q2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding RUBY and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20250$0
Q3 20250$0
Q2 20250$0
Q1 20250$0
Q4 20240$0
Q3 20240$0
Q2 20240$0
Q1 20240$0
Q4 20230$0
Q3 20230$0
Q2 20230$0
Q1 20237$61.3K
Q4 202242$11.2M
Q3 202262$29.7M
Q2 202273$66.6M
Q1 2022117$493.9M
Q4 2021108$863.6M
Q3 2021105$1.55B
Q2 2021108$2.09B
Q1 2021105$2.23B

Institutions, Q2 2023

Shares, value and share of portfolio for each institution holding Rubius Therapeutics, Inc.; share changes are against Q1 2023.

Institutions holding RUBY in Q2 2023
InstitutionSharesValue% of portfolioChange in sharesAction
Artal Group S.A.0$00.00%−2,042,666−100.0%Sold out
State of Michigan Retirement System0$00.00%−640,000−100.0%Sold out
Acadian Asset Management LLC0$00.00%−179,676−100.0%Sold out
Baader Bank INC0$00.00%−73,420−100.0%Sold out
Clarius Group, LLC0$00.00%−21,393−100.0%Sold out
Simplex Trading, LLC0$00.00%−3,856−100.0%Sold out
Tower Research Capital LLC (TRC)0$00.00%−25−100.0%Sold out